Tag:
Synflorix
Latest Headlines
Latest Headlines
Argentina fines GSK $93K for Synflorix vaccine trial
Argentina's government has fined GlaxoSmithKline ( $GSK ) $93,000 for its management of trials of the vaccine Synflorix in which 14 babies died. This case brings to light questions as to how big...
Pfizer and GSK boost pneumonia vaccine price cuts for developing world
Just in time for the holiday season, Pfizer ( $PFE ) and GlaxoSmithKline ( $GSK ) said they are selling an additional 360 million doses of their pneumonia vaccine to a global health organization at a
Vaccine gives dangerous pneumococcus strains an opening
When a vaccine that guards against the most common causes of pneumococcal disease comes to the market, it's simultaneously creating fresh opportunities for strains not covered in the shot, scientists
GSK under fire for delay of new vax program
GlaxoSmithKline made a splash in the media several months ago when it joined with Pfizer and announced that it would supply 30 million doses of vaccine each year to protect children in developing
GSK, Pfizer discount vaccines for poor
Over the next 10 years, kids in developing countries will see a stream of discounted vaccines from Pfizer and GlaxoSmithKline. The two drugmakers have inked a long-term vaccine deal with the GAVI
GSK gets bad press in U.S., Argentina
Families in Argentina are saying GlaxoSmithKline tricked them into participating in an experimental vaccine trial by telling them their children were receiving medical treatment, according to an ABC
Glaxo touts effectiveness of pediatric vaccine candidate
GlaxoSmithKline is touting new, late-stage data that demonstrates how its experimental pediatric vaccine Synflorix effectively protects children from pneumococcal disease. Glaxo filed Synflorix for
